Tower Research Capital LLC (Trc) Halozyme Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,126 shares of HALO stock, worth $1.17 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,126
Previous 4,124
388.02%
Holding current value
$1.17 Million
Previous $235,000
309.36%
% of portfolio
0.02%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding HALO
# of Institutions
540Shares Held
123MCall Options Held
689KPut Options Held
205K-
Black Rock Inc. New York, NY17.6MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$774 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$419 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$243 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$201 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.12B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...